|
業務類別
|
Biotechnology |
|
業務概覽
|
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer'sdisease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and severalother compounds in different stages of clinical and pre-clinical development. |
| 公司地址
| 51 West 52nd Street, 7th Floor, New York, NY, USA, 10019 |
| 電話號碼
| +1 844 689-3939 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.anavex.com |
| 員工數量
| 34 |
| Dr. Christopher U. Missling, PhD |
Director, President, Chief Executive Officer and Secretary |
美元 700.00K |
25/11/2025 |
| Ms. Sandra Boenisch, C.G.A.,C.P.A. |
Principal Financial Officer, Principal Accounting Officer and Treasurer |
美元 201.47K |
25/11/2025 |
|
|
| Mr. Athanasios Skarpelos |
Independent Director |
25/11/2025 |
| Dr. Christopher U. Missling, PhD |
Director, President, Chief Executive Officer and Secretary |
25/11/2025 |
| Dr. Axel Paeger, M.B.A.,M.D. |
Independent Director |
25/02/2026 |
| Dr. Steffen Thomas, PhD |
Independent Director |
25/11/2025 |
| Dr. Peter Donhauser, D.O. |
Independent Director |
25/11/2025 |
| Dr. Claus van der Velden, PhD |
Independent Director |
25/11/2025 |
| Dr. Jiong Ma, PhD |
Chairman of the Board |
25/11/2025 |
|
|
|
|
